http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5700760-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2005-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_110d845283f1e5de1758afd302a7a8b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e0f2a19c12cbdaa5bdbf3df815fd6ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3d7b99cac5d4ea62d237ff45878063a |
| publicationDate | 2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-5700760-A2 |
| titleOfInvention | NEW COMPOSITIONS OF DRUGS BASED ON NEW ANTI-COLINERGIC AND INHIBITORS OF EGFR-QUINASA |
| abstract | 1.- Medication, characterized by a content in one or several anticholinergics of the formula 1 wherein X ¯ means a negatively charged anion once, preferably an anion chosen from the group consisting of chloride, bromide, iodide, sulfate, phosphate, methanesulfonate, nitrate , maleate, acetate, citrate, fumarate, tartrate, oxalate, succinate, benzoate and p-toluenesulfonate. in combination with one or more EGFR-kinase inhibitors (2), possibly in the form of their enantiomers, mixtures of the enantiomers or in the form of the racemates, possibly in the form of the solvates or hydrates, as well as, possibly, together with a pharmaceutically compatible adjuvant. 2. A medicament according to claim 1, characterized in that the active ingredients 1 and 2 are contained in a single administration form or in two separate administration forms. 3. A medicament according to one of claims 1 or 2, characterized in that in the compounds of the formula 1 X ¯ means a negatively charged anion once, selected from the group of chloride, bromide, p-toluenesulfonate and methanesulfonate. 4. Medication according to one of claims 1 to 3, characterized in that in the compounds of the formula 1 X ¯ represents bromide. |
| priorityDate | 2005-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.